Reports: ZORA Program (Slovenia): Difference between revisions
No edit summary |
No edit summary |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forpolicymakers</span> | |||
<span style="display:none">sloveniacountry</span> | |||
Go back to [[Slovenia]] page | Go back to [[Slovenia]] page | ||
'''Sponsor, manager or home institution:''' Ljubljana Oncology Institute; ZORA Program. | '''Primary purpose:''' To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years. | ||
'''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]]. | |||
'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines ([[availableVariable::screening]]); The number of new patients in a given year; (RMV [[availableVariable::cancer incidence|incidence]] rate); [[availableVariable::number of deaths|Mortality]] due to RMV; [[availableVariable::causes of death]]; The ratio between the number of newly detected precancerous and cancerous changes per [[availableVariable::year]]. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more]. | |||
''' | '''Data level:''' [[dataLevel::national level]]. | ||
''' | '''Cancer areas of interest:''' [[hasCancerType::C51-C58: Female genitalia cancer]]. [https://zora.onko-i.si/program-zora/namen-in-cilji Click here to learn more]. | ||
''' | '''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access]. | ||
<span style="display:none">Vulva</span> | |||
<span style="display:none">Vagina</span> | |||
<span style="display:none">Cervix</span> | |||
<span style="display:none">Uterus</span> | |||
<span style="display:none">Ovary</span> | |||
<span style="display:none">Fallopian tubes</span> | |||
<span style="display:none">Endometrium</span> | |||
<span style="display:none">dataOwner::Ljubljana Oncology Institute</span> | |||
<span style="display:none">dataOwner::ZORA Program</span> | |||
<span style="display:none">availableVariable::screening</span> | |||
<span style="display:none">availableVariable::cancer incidence|incidence</span> | |||
<span style="display:none">availableVariable::number of deaths|Mortality</span> | |||
<span style="display:none">availableVariable::causes of death</span> | |||
<span style="display:none">availableVariable::year</span> | |||
<span style="display:none">dataLevel::national level</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> | |||
<span style="display:none">isReport</span> | |||
Latest revision as of 16:48, 4 December 2025
Go back to Slovenia page
Primary purpose: To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.
Sponsor, manager or home institution: Ljubljana Oncology Institute; ZORA Program.
Type of information: The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; causes of death; The ratio between the number of newly detected precancerous and cancerous changes per year. Click here to learn more.
Data level: national level.
Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.
Access to information: Click here to access.
